Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare Nanomedicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nanoparticle Drug
1.2.3 Nanocarrier Drug
1.3 Market by Application
1.3.1 Global Healthcare Nanomedicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare Nanomedicine Market Perspective (2018-2029)
2.2 Healthcare Nanomedicine Growth Trends by Region
2.2.1 Global Healthcare Nanomedicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Healthcare Nanomedicine Historic Market Size by Region (2018-2024)
2.2.3 Healthcare Nanomedicine Forecasted Market Size by Region (2024-2029)
2.3 Healthcare Nanomedicine Market Dynamics
2.3.1 Healthcare Nanomedicine Industry Trends
2.3.2 Healthcare Nanomedicine Market Drivers
2.3.3 Healthcare Nanomedicine Market Challenges
2.3.4 Healthcare Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare Nanomedicine Players by Revenue
3.1.1 Global Top Healthcare Nanomedicine Players by Revenue (2018-2024)
3.1.2 Global Healthcare Nanomedicine Revenue Market Share by Players (2018-2024)
3.2 Global Healthcare Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare Nanomedicine Revenue
3.4 Global Healthcare Nanomedicine Market Concentration Ratio
3.4.1 Global Healthcare Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanomedicine Revenue in 2022
3.5 Healthcare Nanomedicine Key Players Head office and Area Served
3.6 Key Players Healthcare Nanomedicine Product Solution and Service
3.7 Date of Enter into Healthcare Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare Nanomedicine Breakdown Data by Type
4.1 Global Healthcare Nanomedicine Historic Market Size by Type (2018-2024)
4.2 Global Healthcare Nanomedicine Forecasted Market Size by Type (2024-2029)
5 Healthcare Nanomedicine Breakdown Data by Application
5.1 Global Healthcare Nanomedicine Historic Market Size by Application (2018-2024)
5.2 Global Healthcare Nanomedicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Healthcare Nanomedicine Market Size (2018-2029)
6.2 North America Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Healthcare Nanomedicine Market Size by Country (2018-2024)
6.4 North America Healthcare Nanomedicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare Nanomedicine Market Size (2018-2029)
7.2 Europe Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Healthcare Nanomedicine Market Size by Country (2018-2024)
7.4 Europe Healthcare Nanomedicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare Nanomedicine Market Size (2018-2029)
8.2 Asia-Pacific Healthcare Nanomedicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Healthcare Nanomedicine Market Size by Region (2018-2024)
8.4 Asia-Pacific Healthcare Nanomedicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare Nanomedicine Market Size (2018-2029)
9.2 Latin America Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Healthcare Nanomedicine Market Size by Country (2018-2024)
9.4 Latin America Healthcare Nanomedicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare Nanomedicine Market Size (2018-2029)
10.2 Middle East & Africa Healthcare Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Healthcare Nanomedicine Market Size by Country (2018-2024)
10.4 Middle East & Africa Healthcare Nanomedicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Healthcare Nanomedicine Introduction
11.1.4 Amgen Revenue in Healthcare Nanomedicine Business (2018-2024)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Healthcare Nanomedicine Introduction
11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanomedicine Business (2018-2024)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 UCB
11.3.1 UCB Company Detail
11.3.2 UCB Business Overview
11.3.3 UCB Healthcare Nanomedicine Introduction
11.3.4 UCB Revenue in Healthcare Nanomedicine Business (2018-2024)
11.3.5 UCB Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Healthcare Nanomedicine Introduction
11.4.4 Roche Revenue in Healthcare Nanomedicine Business (2018-2024)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Healthcare Nanomedicine Introduction
11.5.4 Celgene Revenue in Healthcare Nanomedicine Business (2018-2024)
11.5.5 Celgene Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Healthcare Nanomedicine Introduction
11.6.4 Sanofi Revenue in Healthcare Nanomedicine Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Detail
11.7.2 Merck & Co Business Overview
11.7.3 Merck & Co Healthcare Nanomedicine Introduction
11.7.4 Merck & Co Revenue in Healthcare Nanomedicine Business (2018-2024)
11.7.5 Merck & Co Recent Development
11.8 Biogen
11.8.1 Biogen Company Detail
11.8.2 Biogen Business Overview
11.8.3 Biogen Healthcare Nanomedicine Introduction
11.8.4 Biogen Revenue in Healthcare Nanomedicine Business (2018-2024)
11.8.5 Biogen Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Detail
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Healthcare Nanomedicine Introduction
11.9.4 Gilead Sciences Revenue in Healthcare Nanomedicine Business (2018-2024)
11.9.5 Gilead Sciences Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Healthcare Nanomedicine Introduction
11.10.4 Pfizer Revenue in Healthcare Nanomedicine Business (2018-2024)
11.10.5 Pfizer Recent Development
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Detail
11.11.2 Leadiant Biosciences Business Overview
11.11.3 Leadiant Biosciences Healthcare Nanomedicine Introduction
11.11.4 Leadiant Biosciences Revenue in Healthcare Nanomedicine Business (2018-2024)
11.11.5 Leadiant Biosciences Recent Development
11.12 Kyowa Hakko Kirin
11.12.1 Kyowa Hakko Kirin Company Detail
11.12.2 Kyowa Hakko Kirin Business Overview
11.12.3 Kyowa Hakko Kirin Healthcare Nanomedicine Introduction
11.12.4 Kyowa Hakko Kirin Revenue in Healthcare Nanomedicine Business (2018-2024)
11.12.5 Kyowa Hakko Kirin Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Healthcare Nanomedicine Introduction
11.13.4 Takeda Revenue in Healthcare Nanomedicine Business (2018-2024)
11.13.5 Takeda Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Detail
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Healthcare Nanomedicine Introduction
11.14.4 Ipsen Revenue in Healthcare Nanomedicine Business (2018-2024)
11.14.5 Ipsen Recent Development
11.15 Endo International
11.15.1 Endo International Company Detail
11.15.2 Endo International Business Overview
11.15.3 Endo International Healthcare Nanomedicine Introduction
11.15.4 Endo International Revenue in Healthcare Nanomedicine Business (2018-2024)
11.15.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Healthcare Nanomedicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Nanoparticle Drug
Table 3. Key Players of Nanocarrier Drug
Table 4. Global Healthcare Nanomedicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Healthcare Nanomedicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Healthcare Nanomedicine Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Healthcare Nanomedicine Market Share by Region (2018-2024)
Table 8. Global Healthcare Nanomedicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Healthcare Nanomedicine Market Share by Region (2024-2029)
Table 10. Healthcare Nanomedicine Market Trends
Table 11. Healthcare Nanomedicine Market Drivers
Table 12. Healthcare Nanomedicine Market Challenges
Table 13. Healthcare Nanomedicine Market Restraints
Table 14. Global Healthcare Nanomedicine Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Healthcare Nanomedicine Market Share by Players (2018-2024)
Table 16. Global Top Healthcare Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanomedicine as of 2022)
Table 17. Ranking of Global Top Healthcare Nanomedicine Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Healthcare Nanomedicine Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Healthcare Nanomedicine Product Solution and Service
Table 21. Date of Enter into Healthcare Nanomedicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Healthcare Nanomedicine Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Healthcare Nanomedicine Revenue Market Share by Type (2018-2024)
Table 25. Global Healthcare Nanomedicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Healthcare Nanomedicine Revenue Market Share by Type (2024-2029)
Table 27. Global Healthcare Nanomedicine Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Healthcare Nanomedicine Revenue Market Share by Application (2018-2024)
Table 29. Global Healthcare Nanomedicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Healthcare Nanomedicine Revenue Market Share by Application (2024-2029)
Table 31. North America Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Healthcare Nanomedicine Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Healthcare Nanomedicine Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Healthcare Nanomedicine Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Healthcare Nanomedicine Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Healthcare Nanomedicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Healthcare Nanomedicine Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Healthcare Nanomedicine Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Healthcare Nanomedicine Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Healthcare Nanomedicine Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Healthcare Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Healthcare Nanomedicine Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Healthcare Nanomedicine Market Size by Country (2024-2029) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Healthcare Nanomedicine Product
Table 49. Amgen Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Teva Pharmaceuticals Company Detail
Table 52. Teva Pharmaceuticals Business Overview
Table 53. Teva Pharmaceuticals Healthcare Nanomedicine Product
Table 54. Teva Pharmaceuticals Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 55. Teva Pharmaceuticals Recent Development
Table 56. UCB Company Detail
Table 57. UCB Business Overview
Table 58. UCB Healthcare Nanomedicine Product
Table 59. UCB Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 60. UCB Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Healthcare Nanomedicine Product
Table 64. Roche Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Celgene Company Detail
Table 67. Celgene Business Overview
Table 68. Celgene Healthcare Nanomedicine Product
Table 69. Celgene Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 70. Celgene Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Healthcare Nanomedicine Product
Table 74. Sanofi Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Merck & Co Company Detail
Table 77. Merck & Co Business Overview
Table 78. Merck & Co Healthcare Nanomedicine Product
Table 79. Merck & Co Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 80. Merck & Co Recent Development
Table 81. Biogen Company Detail
Table 82. Biogen Business Overview
Table 83. Biogen Healthcare Nanomedicine Product
Table 84. Biogen Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 85. Biogen Recent Development
Table 86. Gilead Sciences Company Detail
Table 87. Gilead Sciences Business Overview
Table 88. Gilead Sciences Healthcare Nanomedicine Product
Table 89. Gilead Sciences Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 90. Gilead Sciences Recent Development
Table 91. Pfizer Company Detail
Table 92. Pfizer Business Overview
Table 93. Pfizer Healthcare Nanomedicine Product
Table 94. Pfizer Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Leadiant Biosciences Company Detail
Table 97. Leadiant Biosciences Business Overview
Table 98. Leadiant Biosciences Healthcare Nanomedicine Product
Table 99. Leadiant Biosciences Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 100. Leadiant Biosciences Recent Development
Table 101. Kyowa Hakko Kirin Company Detail
Table 102. Kyowa Hakko Kirin Business Overview
Table 103. Kyowa Hakko Kirin Healthcare Nanomedicine Product
Table 104. Kyowa Hakko Kirin Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 105. Kyowa Hakko Kirin Recent Development
Table 106. Takeda Company Detail
Table 107. Takeda Business Overview
Table 108. Takeda Healthcare Nanomedicine Product
Table 109. Takeda Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 110. Takeda Recent Development
Table 111. Ipsen Company Detail
Table 112. Ipsen Business Overview
Table 113. Ipsen Healthcare Nanomedicine Product
Table 114. Ipsen Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 115. Ipsen Recent Development
Table 116. Endo International Company Detail
Table 117. Endo International Business Overview
Table 118. Endo International Healthcare Nanomedicine Product
Table 119. Endo International Revenue in Healthcare Nanomedicine Business (2018-2024) & (US$ Million)
Table 120. Endo International Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare Nanomedicine Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Healthcare Nanomedicine Market Share by Type: 2022 VS 2029
Figure 3. Nanoparticle Drug Features
Figure 4. Nanocarrier Drug Features
Figure 5. Global Healthcare Nanomedicine Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Healthcare Nanomedicine Market Share by Application: 2022 VS 2029
Figure 7. Anticancer Case Studies
Figure 8. CNS Product Case Studies
Figure 9. Anti-infective Case Studies
Figure 10. Other Case Studies
Figure 11. Healthcare Nanomedicine Report Years Considered
Figure 12. Global Healthcare Nanomedicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Healthcare Nanomedicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Healthcare Nanomedicine Market Share by Region: 2022 VS 2029
Figure 15. Global Healthcare Nanomedicine Market Share by Players in 2022
Figure 16. Global Top Healthcare Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Nanomedicine as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Healthcare Nanomedicine Revenue in 2022
Figure 18. North America Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Healthcare Nanomedicine Market Share by Country (2018-2029)
Figure 20. United States Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Healthcare Nanomedicine Market Share by Country (2018-2029)
Figure 24. Germany Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Healthcare Nanomedicine Market Share by Region (2018-2029)
Figure 32. China Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Healthcare Nanomedicine Market Share by Country (2018-2029)
Figure 40. Mexico Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Healthcare Nanomedicine Market Share by Country (2018-2029)
Figure 44. Turkey Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Healthcare Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Amgen Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 48. UCB Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 49. Roche Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 50. Celgene Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 51. Sanofi Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 52. Merck & Co Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 53. Biogen Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 55. Pfizer Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 56. Leadiant Biosciences Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 57. Kyowa Hakko Kirin Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 58. Takeda Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 59. Ipsen Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 60. Endo International Revenue Growth Rate in Healthcare Nanomedicine Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed